ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Not for the Faint of Heart: The Impact of Post-Reperfusion Syndrome during Liver Transplantation Using Livers with Significant Macrosteatosis

K. P. Croome, D. Lee, S. Croome, R. Chadha, D. Livingston, P. Abader, A. P. Keaveny, C. Taner

Mayo Clinic, Jacksonville, FL

Meeting: 2019 American Transplant Congress

Abstract number: 337

Keywords: Donors, marginal, Liver grafts

Session Information

Session Name: Concurrent Session: Liver: MELD, Allocation and Donor Issues (DCD/ECD) II

Session Type: Concurrent Session

Date: Monday, June 3, 2019

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:30pm-4:42pm

Location: Room 302

*Purpose: The present study represents the largest series of donor livers with moderate macrosteatosis and provides detailed analysis of the effects of post reperfusion syndrome (PRS) and its impact on both short and long-term outcomes. PRS is an immediate complication of hemodynamic instability, asystole or the need to start the infusion of vasopressors during the post-reperfusion period. This study aims to describe the real peri-operative dangers of utilizing donor livers with significant macrosteatosis.

*Methods: Clinical outcomes of all patients undergoing LT with donor livers with Moderate Macrosteatosis (30-60%)(N = 96) between 2000-2017 were compared to a propensity score matched cohort of patients undergoing LT with donor livers with No Steatosis(N = 96).

*Results: Cardiac arrest at the time of reperfusion was seen in 8(8.3%) of the patients in the Moderate Macrosteatosis group compared to 0(0%) of patients in the No Steatosis group (p=0.004). Patients in the Moderate Macrosteatosis group had a higher rate of PRS (37.5%vs.18.8%; p=0.004), early allograft dysfunction (EAD) (76.4%vs.25.8%;p<0.001), renal dysfunction requiring CRRT following transplant (18.8%vs.8.3%;p=0.03) and return to the OR within 30 days (24.0%vs.7.3%;p=0.002), than the No Steatosis Group. Both long-term patient (p=0.08) and graft survival(p=0.12) were not different between the 2 groups.

 border=

*Conclusions: Recipients of LT using livers with moderate macrosteatosis are at a significant increased risk of PRS. If patients are able to overcome the initial peri-operative risk of using these donor livers, long-term graft survival does not appear to be different than matched recipients receiving grafts with no steatosis.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Croome KP, Lee D, Croome S, Chadha R, Livingston D, Abader P, Keaveny AP, Taner C. Not for the Faint of Heart: The Impact of Post-Reperfusion Syndrome during Liver Transplantation Using Livers with Significant Macrosteatosis [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/not-for-the-faint-of-heart-the-impact-of-post-reperfusion-syndrome-during-liver-transplantation-using-livers-with-significant-macrosteatosis/. Accessed May 8, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences